Literature DB >> 28379323

Subclinical atrial fibrillation in need of more assertive evidence.

Kazem Rahimi1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28379323      PMCID： PMC5837597          DOI： 10.1093/eurheartj/ehx122

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  13 in total

1.  Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation.

Authors:  David Conen; Jorge A Wong; Roopinder K Sandhu; Nancy R Cook; I-Min Lee; Julie E Buring; Christine M Albert
Journal:  JAMA Cardiol       Date:  2016-07-01       Impact factor: 14.676

2.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas; Stefan Agewall; John Camm; Gonzalo Baron Esquivias; Werner Budts; Scipione Carerj; Filip Casselman; Antonio Coca; Raffaele De Caterina; Spiridon Deftereos; Dobromir Dobrev; José M Ferro; Gerasimos Filippatos; Donna Fitzsimons; Bulent Gorenek; Maxine Guenoun; Stefan H Hohnloser; Philippe Kolh; Gregory Y H Lip; Athanasios Manolis; John McMurray; Piotr Ponikowski; Raphael Rosenhek; Frank Ruschitzka; Irina Savelieva; Sanjay Sharma; Piotr Suwalski; Juan Luis Tamargo; Clare J Taylor; Isabelle C Van Gelder; Adriaan A Voors; Stephan Windecker; Jose Luis Zamorano; Katja Zeppenfeld
Journal:  Eur J Cardiothorac Surg       Date:  2016-09-23       Impact factor: 4.191

3.  Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers.

Authors:  Maday Gonzalez; Richard J Keating; Steven M Markowitz; Christopher F Liu; George Thomas; James E Ip; Bruce B Lerman; Jim W Cheung
Journal:  Heart Rhythm       Date:  2014-08-15       Impact factor: 6.343

4.  Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy.

Authors:  Christoffer Tobias Witt; Mads Brix Kronborg; Ellen Aagaard Nohr; Peter Thomas Mortensen; Christian Gerdes; Jens Cosedis Nielsen
Journal:  Heart Rhythm       Date:  2015-07-08       Impact factor: 6.343

5.  Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.

Authors:  Giovanni L Botto; Luigi Padeletti; Massimo Santini; Alessandro Capucci; Michele Gulizia; Francesco Zolezzi; Stefano Favale; Giulio Molon; Renato Ricci; Mauro Biffi; Giovanni Russo; Marco Vimercati; Giorgio Corbucci; Giuseppe Boriani
Journal:  J Cardiovasc Electrophysiol       Date:  2008-10-30

Review 6.  The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis.

Authors:  Anand N Ganesan; Derek P Chew; Trent Hartshorne; Joseph B Selvanayagam; Philip E Aylward; Prashanthan Sanders; Andrew D McGavigan
Journal:  Eur Heart J       Date:  2016-02-16       Impact factor: 29.983

7.  Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.

Authors:  Isabelle C Van Gelder; Jeff S Healey; Harry J G M Crijns; Jia Wang; Stefan H Hohnloser; Michael R Gold; Alessandro Capucci; Chu-Pak Lau; Carlos A Morillo; Anne H Hobbelt; Michiel Rienstra; Stuart J Connolly
Journal:  Eur Heart J       Date:  2017-05-01       Impact factor: 29.983

8.  Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population.

Authors:  Nesan Shanmugam; Annegret Boerdlein; Jochen Proff; Peter Ong; Oswaldo Valencia; Sebastian K G Maier; Wolfgang R Bauer; Vince Paul; Stefan Sack
Journal:  Europace       Date:  2011-09-20       Impact factor: 5.214

9.  Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).

Authors:  Giuseppe Boriani; Taya V Glotzer; Massimo Santini; Teena M West; Mirko De Melis; Milan Sepsi; Maurizio Gasparini; Thorsten Lewalter; John A Camm; Daniel E Singer
Journal:  Eur Heart J       Date:  2013-12-11       Impact factor: 29.983

10.  Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults.

Authors:  Connor A Emdin; Simon G Anderson; Gholamreza Salimi-Khorshidi; Mark Woodward; Stephen MacMahon; Terrence Dwyer; Kazem Rahimi
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196
View more
  3 in total

1.  Recurrence rate of atrial fibrillation after the first clinical episode: A prospective evaluation using continuous cardiac rhythm monitoring.

Authors:  Emmanuel N Simantirakis; Panteleimon E Papakonstantinou; Emmanuel Kanoupakis; Gregory I Chlouverakis; Stylianos Tzeis; Panos E Vardas
Journal:  Clin Cardiol       Date:  2018-05-14       Impact factor: 2.882

2.  Atrial fibrillation: villain or bystander in vascular brain injury.

Authors:  Ben Freedman; Hooman Kamel; Isabelle C Van Gelder; Renate B Schnabel
Journal:  Eur Heart J Suppl       Date:  2020-12-06       Impact factor: 1.803

3.  Self-palpation for detection of paroxysmal atrial fibrillation: Much noise with little signal.

Authors:  Kazem Rahimi; Paulus Kirchhof
Journal:  PLoS Med       Date:  2020-03-31       Impact factor: 11.069
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.